Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESP Block vs Intrathecal Morphine for Post-Cesarean Analgesia
NCT04256642Phase 3Unknown
- Sponsor
- McGill University Health Centre
- Start
- Feb 2020
- Primary completion
- Jan 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ropivacaine in Post-cesarean pain, sponsored by McGill University Health Centre. Status: unknown.
02
Drugs
ropivacaine
03
Conditions
Post-cesarean pain
Beyond the preview
Go deeper on NCT04256642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04256642.